Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 10, 2017 (9 years ago)

Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Phenylephrine 1000 mcg in 0.9% Sodium Chloride 10 mL, 10 mL syringe, Concentration: 100 mcg/mL. This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO --- NDC: 88890-0104-01

Affected NDC 88890-0104-01

Compare with the code on your package — it is the most precise check available.

Drug: Phenylephrine

Recalling firm
SSM Health Care St. Louis DBA SSM St. Clare Health Center
Origin
MO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0144-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Phenylephrine recalls

See all

Other recalls by SSM Health Care St. Louis DBA SSM St. Clare Health Center

All 2017 recalls
Class II · Moderate risk

FentaNYL citrate

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0436-2024
Class II · Moderate risk

Phenylephrine HCl

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0435-2024
Class II · Moderate risk

HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Ongoing cGMP deviation SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0776-2023